Product
Granulocyte-macrophage colony-stimulating factor
2 clinical trials
3 indications
Indication
triple-negative breast cancerIndication
Advanced Solid TumorIndication
Refractory TumorClinical trial
A Phase Ib, Open-Label, Multicohort Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Patients With Triple-Negative Breast CancerStatus: Completed, Estimated PCD: 2023-03-08
Clinical trial
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor (Endo) in Combination With Bragg Treatment for Advanced Refractory Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-12-30